Trial Profile
Safety and tolerability of 68Ga-DOTATOC for injection in patients with proven gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs).
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Mar 2019
Price :
$35
*
At a glance
- Drugs Gallium 68-DOTATOC (Primary)
- Indications Gastric cancer; Neuroendocrine tumours; Pancreatic cancer
- Focus Adverse reactions
- Sponsors Advanced Accelerator Applications
- 01 Apr 2015 New trial record